Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response	Immune Checkpoint Inhibitors; Locally Advanced Non-small Cell Lung Cancer (NSCLC); Neoadjuvant Chemoimmunotherapy; Thoracic Radiotherapy	Not yet recruiting	Phase 2	2026-06-26		NCT07670715

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tianjin Medical University Cancer Institute and Hospital	287

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tianjin Medical University Cancer Institute & Hospital	Tianjin	China	20

Clinical trials